Remodulin Hospital
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 2636, Seattle, Washington, 98111,...Phone Number
(866) 505-7337Website
www.remodulin.comRevenue
$13.7 MillionIndustry
About Remodulin Hospital
Is Remodulin Hospital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Remodulin Hospital has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Remodulin Hospital had a recent Job posting/layoffs
Remodulin Hospital, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Remodulin Hospital has recently received funding, and reach out quickly before it becomes old news!
Check out if Remodulin Hospital is spiking on competitors!
Product Launch: Get notified when Remodulin Hospital launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Remodulin Hospital
Earning: See what the market has to say on Remodulin Hospital recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Remodulin Hospital
Compare insights from companies similar to Remodulin Hospital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Remodulin Hospital is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Remodulin Hospital is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Remodulin Hospital.
Remodulin Hospital Tech Stack
A closer look at the technologies used by Remodulin Hospital
Remodulin Hospital News & Media
United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for the use of Remodulin (treprostinil) Injection in...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Remodulin Hospital
As the most prescribed pump therapy for PAH, Remodulin has been trusted by patients and their doctors time and time again. With Remodulin, you are not alone. You also have access to support programs and resources from United Therapeutics, a company founded to support people with PAH to help you get the most from therapy. How will Remodulin change m... Read More